These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28471528)

  • 1. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.
    Thompson KM
    Risk Anal; 2017 Jun; 37(6):1041-1051. PubMed ID: 28471528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and Managing the Risks of Measles and Rubella: A Global Perspective, Part I.
    Thompson KM; Cochi SL
    Risk Anal; 2016 Jul; 36(7):1288-96. PubMed ID: 27424287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priorities for global measles and rubella control and eradication.
    Goodson JL; Chu SY; Rota PA; Moss WJ; Featherstone DA; Vijayaraghavan M; Thompson KM; Martin R; Reef S; Strebel PM
    Vaccine; 2012 Jul; 30(32):4709-16. PubMed ID: 22549089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradicating Measles: A Call for an Exceptional Coordinated Global Effort.
    Durrheim DN; Andrus JK; Pfaff G; Tabassum S; Bashour H; Githanga D
    J Infect Dis; 2019 Nov; 220(12):1870-1872. PubMed ID: 30615164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [German Measles has been eradicated in Americas thanks to vaccination].
    Nau JY
    Rev Med Suisse; 2015 May; 11(474):1090-1. PubMed ID: 26118235
    [No Abstract]   [Full Text] [Related]  

  • 8. Combining Global Elimination Of Measles And Rubella With Strengthening Of Health Systems In Developing Countries.
    Andrus JK; Cochi SL; Cooper LZ; Klein JD
    Health Aff (Millwood); 2016 Feb; 35(2):327-33. PubMed ID: 26858388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elimination of measles and rubella in Germany: Progress and hindrances].
    Pfaff G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1222-4. PubMed ID: 23990082
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility assessment of measles and rubella eradication.
    Moss WJ; Shendale S; Lindstrand A; O'Brien KL; Turner N; Goodman T; Kretsinger K; ;
    Vaccine; 2021 Jun; 39(27):3544-3559. PubMed ID: 34045102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
    Kretsinger K; Strebel P; Kezaala R; Goodson JL
    J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plan for the Elimination of Measles and Rubella in Spain].
    Limia Sánchez A
    Rev Esp Salud Publica; 2015; 89(4):393-6. PubMed ID: 26580794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention.
    Thompson KM; Strebel PM; Dabbagh A; Cherian T; Cochi SL
    Vaccine; 2013 Apr; 31 Suppl 2():B149-56. PubMed ID: 23598476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principles and feasibility of disease eradication.
    Dowdle WR; Cochi SL
    Vaccine; 2011 Dec; 29 Suppl 4():D70-3. PubMed ID: 22188936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.
    Brown KE; Rota PA; Goodson JL; Williams D; Abernathy E; Takeda M; Mulders MN
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(26):587-591. PubMed ID: 31269012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
    Orenstein WA; Hinman A; Nkowane B; Olive JM; Reingold A
    Vaccine; 2018 Jan; 36 Suppl 1():A1-A34. PubMed ID: 29307367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.